Redx has appointed Lisa Anson as CEO and to its Board of Directors. Lisa will take up both roles on 1 June 2018. At that time Iain Ross, currently executive chairman, will revert to being non-executive chairman.
Lisa Anson, aged 49, has been president of AstraZeneca UK since 2012 and brings significant leadership experience to the role. Over a 20 year career with AstraZeneca, Lisa has held a variety of senior management roles at AstraZeneca in both the US and the UK including global vice president oncology and vice president of emerging brands working closely with the research and development teams. Lisa is the current President of the Association of the British Pharmaceutical Industry (ABPI).
